Fig. 1From: SGLT-2 inhibitors and cardiorenal outcomes in patients with or without type 2 diabetes: a meta-analysis of 11 CVOTsForest plots examining the first outcome of CV death or hospitalization for heart failure in participants of 11 CVOTs irrespective of the presence of type 2 diabetes. There is a low and not significant heterogeneity in the analysis (I2 = 23%, P = 0.20)Back to article page